By: Amy Jo Underwood
A volunteer in Oxford University’s COVID-19 vaccine trial has died, although Brazil continues into the third and final phase of the trial. No details were given on the death of the volunteer, but the Brazilian government has stated its intent to purchase the vaccine and produce it as competition to the vaccine being tested in China.
Oxford University has been conducting trials on a Coronavirus vaccine for several months, according to the U.K.’s Express. Health authorities have confirmed that one individual has died as a result of the trials, but no further information was given surrounding the volunteer’s death.
According to the Washington Post, the volunteer may have been in a control group that did not receive the vaccine. Those in a control group not receiving the vaccine were instead given a vaccine meant for meningitis. However, no details have been given to the trial participants or the press as to who is in each control group, or whether the deceased was given a placebo.
As of now, Brazil continues plans to purchase the vaccine and distribute it.
“Speaking to the Commons and Lords National Security Strategy Committee, [the U.K. chief scientific advisor] stated the virus will not be completely eradicated either. He said: ‘It is unlikely we will end up with a truly sterilising vaccine.’ - Express
“Following careful assessment of this case in Brazil, there have been no concerns about safety of the clinical trial, and the independent review in addition to the Brazilian regulator have recommended that the trial should continue.” - Oxford University
Amy Jo Underwood writes from Alabama